Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flares.

ABSTRACT: People with generalized pustular psoriasis experience underlying skin inflammation, even in the absence of flares. Spesolimab treatment helps control the inflammation and prevent future flares.

SUBMITTER: Krueger JG 

PROVIDER: S-EPMC12404765 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature